Cat. No. | Product Name | Field of Application | Chemical Structure |
---|---|---|---|
DC23816 | BAY-293 racemate |
BAY-293 racemate (BAY293 racemate) is a potent SOS1 inhibitor that disrupts the KRAS-SOS1 interaction with IC50 of 50 nM, the R-enantiomer (BAY-293) is the active form with IC50 of 21 nM, while the BAY-293 is less active (IC50=2,340 nM)..
More description
|
![]() |
DC23438 | BAY 60-6583 |
BAY 60-6583 (BAY606583) is a potent, selective adenosine A2B receptor agonist with EC50 of 2.83 nM (murine A2BR).
More description
|
![]() |
DC20748 | BAY 60-2770 |
BAY 60-2770 is an NO-independent activator of sGC (soluble guanylyl cyclase) with EC50 of 5.4 nM.
More description
|
![]() |
DC20747 | BAY 41-8543 |
BAY 41-8543 is an NO-independent sGC (soluble guanylyl cyclase) stimulator, inhibits collagen-mediated aggregation in washed human platelets (IC50=90 nM).
More description
|
![]() |
DC10291 | Bay 41-4109 less active enantiomer |
Bay 41-4109 less active enantiomer shows less activity than Bay 41-4109. BAY 41-4109 is a potent inhibitor of human hepatitis B virus (HBV) with an IC50 of 53 nM.
More description
|
![]() |
DC23386 | BAY 1238097 |
BAY 1238097 is a novel BET bromodomain inhibitor with IC50 of 50 nM, inhibits the interaction between BRD4, BRD3 or BRD2 and H4 with IC50 values of 63 nM, 609 nM and 2430 nM in the NanoBRET assay.
More description
|
![]() |
DC20750 | BAY 1143269 |
BAY 1143269 is a potent, selective, orally bioavailable inhibitor of MNK1 with enzyme IC50 of 40 nM at 2 mM ATP.
More description
|
![]() |
DC23719 | BAY 1024767 |
BAY 1024767 (BAY1024767) is a higly potent antagonist of androgen receptor (AR) wild-type (IC50=46 nM) and mutant forms located in the AR ligand-binding domain (LBD).
More description
|
![]() |
DC20317 | Barbadin |
Barbadin is a small molecule that selectively inhibits the β-arrestin/β2-adaptin interaction (IC50=19.1/15.6 uM for β-arrestin1/2) without effect on the formation of receptor/β-arrestin complexes.
More description
|
![]() |
DC9562 | Balsalazide |
Balsalazide is an anti-inflammatory compound used in the treatment of Inflammatory Bowel Disease.
More description
|
![]() |
DCAPI1046 | Balofloxacin |
Balofloxacin
More description
|
![]() |
DC20740 | BAL30072 |
BAL30072 is a monocyclic beta-lactam antibiotic that shows potent activity against MDR Pseudomonas aeruginosa and Acinetobacter sp. Isolates with MIC90 of 8 and 4 ug/ml.
More description
|
![]() |
DCAPI1066 | Bacitracin zinc |
Bacitracin zinc
More description
|
![]() |
DC22011 | BAA473 |
BAA473 (BAA-473) is a bile acid analogue that functions as the first small molecule activator of the Pyrin inflammasome, induces secretion of IL18 in LPS-primed PBMCs.
More description
|
![]() |
DC22010 | B591 |
B591 (B-591) is a potent, specific pan-PI3K inhibitor with IC50 of 1.3/0.36/1.1/1.58 uM for PI3Kα/β/γ/δ, respectively.
More description
|
![]() |
DC12114 | B I09 |
B I09 is an IRE-1 RNase inhibitor, with an IC50 of 1230 nM.
More description
|
![]() |
DC23756 | Aβ polymerization stimulator O4 |
Aβ polymerization stimulator O4 is an orcein-related small molecule can drive polymerization of amyloid-β (Aβ).
More description
|
![]() |
DCAPI1341 | Aztreonam (Azactam, Cayston) |
Aztreonam (Azactam, Cayston)
More description
|
![]() |
DC22953 | AZSMO-23 |
AZSMO-23 (AZSMO 23, AZSMO23) is a potent hERG potassium channel (Kv11.1) activator that activates WT hERG pre-pulse and tail current with EC50 of 28.6 and 11.2 μM respectively.
More description
|
![]() |
DCAPI1225 | Azomycin (2-Nitroimidazole) |
Azomycin (2-Nitroimidazole)
More description
|
![]() |
DC4141 | Azocosterol 2HCL |
Azocosterol is a potential avian reproductive inhibitor.
More description
|
![]() |
DCAPI1590 | Azelnidipine |
Azelnidipine is an L-type calcium channel protein inhibitor
More description
|
![]() |
DC10245 | Azelaic acid |
Azelaic acid is an organic compound produced by the ozonolysis of oleic acid and possesses antibacterial, keratolytic, comedolytic, and anti-oxidant activity.
More description
|
![]() |
DC20737 | AZD-9819 |
AZD-9819 is an inhibitor of human neutrophil elastase for potential treatment of chronic obstructive pulmonary disease..
More description
|
![]() |
DC20735 | AZD 8329 |
AZD8329 is a potent, selective 11β-HSD1 inhibitor with IC50 of 9 nM, displays excellent selectivity versus relatedd 11β-HSD2, 17β-HSD1 and 17β-HSD3 (IC50>30 uM).
More description
|
![]() |
DC20734 | AZD-8309 |
AZD-8309 (AZD8309) is a potent and orally bioavailable CXCR2 antagonist that has been proposed to regulate the transmigration of neutrophils.
More description
|
![]() |
DC20733 | AZD-8165 |
AZD-8165 is a potent, selective and oral thrombin inhibitor for treatment of thrombosis..
More description
|
![]() |
DC12553 | AZD6088 |
AZD6088 (AZD-6088) is a potent and selective, orally bioavailable partial agonist of the M1 muscarinic receptor, reduces heat hyperalgesia in SNL rats with an EC50 of 46.6 nM..
More description
|
![]() |
DC22007 | AZD5904 |
AZD5904 (AZD-5904) is a potent, selective irreversible, orally bioavailable myeloperoxidase (MPO) inhibitor with IC50 of 140 nM, similar potency in mouse and rat.
More description
|
![]() |
DC20728 | AZD-5718 |
AZD-5718 is an orally available small molecule, 5-lipoxygenase activating protein (FLAP) inhibitor..
More description
|
![]() |